Yahoo
NSE - Delayed Quote INR

Eris Lifesciences Limited (ERIS.NS)

1,160.20 +3.80 (+0.33%)
At close: 3:30:01 PM GMT+5:30
Chart Range Bar
Loading chart for ERIS.NS
  • Previous Close 1,156.40
  • Open 1,160.00
  • Bid --
  • Ask --
  • Day's Range 1,150.60 - 1,186.90
  • 52 Week Range 1,069.00 - 1,740.00
  • Volume 45,455
  • Avg. Volume 103,961
  • Market Cap (intraday) 160.964B
  • Beta (5Y Monthly) -0.05
  • PE Ratio (TTM) 22.56
  • EPS (TTM) 51.42
  • Earnings Date (est.) --
  • Forward Dividend & Yield 14.42 (1.25%)
  • Ex-Dividend Date May 29, 2026
  • 1y Target Est 1,514.40

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, GLP-1, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram monitoring, continuous glucose monitoring system, sleep device, antenatal care, and early neuropathy screening solutions, as well as polycystic ovary syndrome screening, diagnosis, and management. The company offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

www.eris.co.in

2,758

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ERIS.NS
22.53%
S&P BSE SENSEX (^BSESN)
11.18%

1-Year Return

ERIS.NS
26.72%
S&P BSE SENSEX (^BSESN)
9.82%

3-Year Return

ERIS.NS
35.73%
S&P BSE SENSEX (^BSESN)
18.12%

5-Year Return

ERIS.NS
48.15%
S&P BSE SENSEX (^BSESN)
26.09%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 8.92B
Earnings 1.84B
Profit Margin 20.60%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
2B
4B
6B
8B
15.0%
20.0%
25.0%
30.0%
35.0%

Analyst Insights

View More

Analyst Price Targets

1,140.00
1,514.40 Average
1,160.20 Current
1,780.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.37%

  • Return on Assets (ttm)

    7.42%

  • Return on Equity (ttm)

    18.79%

  • Revenue (ttm)

    33.12B

  • Net Income Avi to Common (ttm)

    7.08B

  • Diluted EPS (ttm)

    51.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.54B

  • Total Debt/Equity (mrq)

    58.66%

  • Levered Free Cash Flow (ttm)

    415.54M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: